Evelo Biosciences Closes IPO

5/13/18

CAMBRIDGE, Mass., May 11, 2018 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO)  announced the closing of its initial public offering of 5,312,500 shares of common stock at a public offering price of $16.00 per share, before underwriting discounts and commissions. In addition, Evelo has granted the underwriters a 30-day option to purchase up to an additional 796,875 shares of common stock at the initial public offering price, less the underwriting discounts and commissions, to cover over-allotments, if any. The company’s common stock began trading on the Nasdaq Global Select Market on May 9, 2018 under the ticker symbol “EVLO.” The gross proceeds of the offering were $85 million, excluding any exercise of the underwriters’ option.

Morgan Stanley, Cowen and BMO Capital Markets acted as book-running managers for the offering. JMP Securities acted as lead manager for the offering.